期刊文献+

蛋白酶体功能与帕金森病相关性实验研究 被引量:1

The Study on the Relationship between Proteasome Function and Parkinson Disease
下载PDF
导出
摘要 目的观察蛋白酶体抑制剂诱导大鼠黑质多巴胺能神经元α-突触核蛋白(-αsynuclein,-αSyn)的表达及聚集,探讨蛋白酶体功能在帕金森病(PD)发病中的作用机制。方法采用立体定向将蛋白酶体抑制剂Lactacys-tin注射至大鼠黑质部位。以免疫荧光法观察黑质区多巴胺能神经元变性缺失,并应用免疫荧光双标法观察多巴胺能神经元内蛋白聚集的包涵体及其主要成分-αSyn的表达,然后通过原位杂交分析-αSyn mRNA表达及Western印迹法检测黑质-αSyn表达量改变。结果注射Lactacystin第7天大鼠开始出现自发性活动减少,阿扑吗啡尚可诱导出旋转行为;3周后患侧黑质部位酪氨酸羟化酶(TH)阳性细胞明显减少。TH与硫磺素、硫磺素与-αSyn复合染色呈阳性。-αSyn mRNA表达量升高,蛋白表达水平增加。结论Lactacystin诱导大鼠黑质细胞-αSyn表达升高并出现蛋白聚集可能是导致PD发病的机制之一。 Objective To investigate α-synuclein expression and aggregation in dopaminergic neurons of rat substantia nigra exposed to proteasome inhibition for the role of proteasome function in the pathogenesis of Parkinson disease. Methods Lactacystin, a proteasomc inhibitor, was unilateral infused stereotaxically into the substantia nigra of rats. The loss of dopamincrgic neurons induced by Lactacystin in the substantia nigra were detected by imunofluorescence staining. The double labeling fluorescence staining was used to observe co-staining of TH and Thioflavinc,as well as Thioflavine and α-synuclein. The level of mRNA of α-synuclein was determined with in situ hybridization and expression of α-synuclcin was detected by Western blotting. Results The rats began to display spontaneous and apomorphinc induced rotation 7 days a(ter Lactacystin injection into the substantia nigra. On the 21 day after the injection of Lactacystin, the loss of TH positive neurons in substantia nigra was observed. The colocalization positive neurons of TH and Thioflavine, Thioflavine and α-synuelein was observed in the imaging of double labeling immunofluorescence. The level of mRNA of α-synuclein was high, Western blotting showed the expression α-synuelein was high as well. Conclusions Laetaeystin can induce up-regulation and aggregation of α-synuclein in the dopamincrgic neurons of substantia nigra, and proteasome maybe act as a main role in the pathogcncsis of Parkinson disease.
出处 《中国神经免疫学和神经病学杂志》 CAS 2005年第6期323-326,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 上海市科委青年科技"启明星后"计划基金资助项目(01QMH1410) 上海市教育发展基金资助项目(03BK24)
关键词 Lactacystin帕金森病 Α-突触核蛋白 聚集 Lactacystin Parkinson discasc α-synuclcin aggregation
  • 相关文献

参考文献10

  • 1Lorenzo A,Yankner BA.Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red [J].Proc Natl Acad Sci USA,1994,91 (25):12243-122437.
  • 2Hardy J,Rideout,Kristin E,et al.Proteasomal inhibition leads to formation of ubiquitin/α-Syn-immunoreactive inclusions in PC12 cells [J].J Neurochem,2001,78:899-908.
  • 3Breit S,Bouali-Benazzouz R,Benabid AL,et al.Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus,which is reversed by the lesion of the subthalamic nucleus in the rat[J].Eur J Neurosci,2001,14:1833-1842.
  • 4McNaught KS,Belezaire R,Isacson O,et al.Altered proteasomal function in Parkinson's disease.[J].Exp Neurol,2003,179:38-46.
  • 5Shastry BS.Neurodegenerative disorders of protein aggregation[J].Neurochem Int,2003,43(1):1-7.
  • 6Lee H J,Choi C,Lee SJ,et al.Membrane-bound α-Syn has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form[J].J Biol Chem,2001,277:671-678.
  • 7Biasin E,Fiorit L,Ceglia I.Proteasome inhibition and aggregation in Parkinson's disease:a comparative study in untransfected and transfected cells [J].J Neurochcm,2004,88 (3):545-553.
  • 8Auluck PK,Chan E,Trojanowski JQ,et al.Chaperone suppression of alpha-synuclein toxicity in a Drosophila model of Parkinson's disease[J].Science,2002,295:865-868.
  • 9Bennett MC,Bishop JF,Leng Y,et al.Degradation of alpha-synuclein by proteasome [J].J Biol Chem,1999,48:33855-33858.
  • 10Paxinou E,Chen Q,Weisse M,et al.Induction of alpha-synuclein aggregation by intracellular nitrative insult[J].J Neurosci,2001,21:8053-8061.

同被引文献7

  • 1Leonid Breydo,Jessica W. Wu,Vladimir N. Uversky.α-Synuclein misfolding and Parkinson’s disease[J].BBA - Molecular Basis of Disease.2011(2)
  • 2Guoqi Zhu,Xuncui Wang,Yuefa Chen,Shu Yang,Hui Cheng,Ning Wang,Qinglin Li.Puerarin Protects Dopaminergic Neurons against 6-Hydroxydopamine Neurotoxicity via Inhibiting Apoptosis and Upregulating Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson’s Disease[J].Planta Med.2010(16)
  • 3Ian N.M. Day,Rod J. Thompson.UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein[J].Progress in Neurobiology.2009(3)
  • 4Mélanie Bourque,Dean E. Dluzen,Thérèse Di Paolo.Neuroprotective actions of sex steroids in Parkinson’s disease[J].Frontiers in Neuroendocrinology.2009(2)
  • 5Yue-Fa Cheng,Guo-Qi Zhu,Mei Wang,Hui Cheng,An Zhou,Ning Wang,Nianbai Fang,Xun-Cui Wang,Xiao-Qiu Xiao,Zhi-Wu Chen,Qing-Lin Li.Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP + -elicited apoptosis[J].Neuroscience Research.2008(1)
  • 6Li Xueli,Sun Shenggang,Tong E’tang.Experimental study on the protective effect of puerarin to Parkinson disease[J].Journal of Huazhong University of Science and Technology.2003(2)
  • 7Kevin St. P. McNaught,Roger Belizaire,Ole Isacson,Peter Jenner,C.Warren Olanow.Altered Proteasomal Function in Sporadic Parkinson’s Disease[J].Experimental Neurology.2002(1)

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部